Nail involvement in patients with moderate-to-severe alopecia areata treated with oral tofacitinib.

Ji Su LeeChang-Hun HuhOhsang KwonHyun-Sun YoonSo Yun Cho Hyun-Sun Park

Published in: The Journal of dermatological treatment (2018)

Oral tofacitinib monotherapy improves nail involvement associated with AA. Nail involvement is not a poor prognosis factor in hair regrowth with tofacitinib treatment and there is no evident relationship between nail and hair responses.

Keyphrases

poor prognosis
rheumatoid arthritis
long non coding rna
ulcerative colitis
clinical trial
early onset
randomized controlled trial
high intensity
drug induced
replacement therapy